0001367644-20-000021.txt : 20200227 0001367644-20-000021.hdr.sgml : 20200227 20200227212615 ACCESSION NUMBER: 0001367644-20-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200225 FILED AS OF DATE: 20200227 DATE AS OF CHANGE: 20200227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SARAN ATUL CENTRAL INDEX KEY: 0001591070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 20665368 MAIL ADDRESS: STREET 1: C/O ZENCOR, INC. STREET 2: 111 WEST LEMON AVENUE CITY: MONROVIA STATE: CA ZIP: 91016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_158285675699451.xml FORM 4 X0306 4 2020-02-25 0 0001367644 Emergent BioSolutions Inc. EBS 0001591070 SARAN ATUL 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Corp Dev, GC & Secretary Common Stock 2020-02-25 4 A 0 5697 0 A 36192 D Common Stock 2020-02-25 4 A 0 5697 0 A 41889 D Common Stock 2020-02-26 4 F 0 508 59.91 D 41381 D Common Stock 2020-02-26 4 F 0 582 59.91 D 40799 D Employee Stock Options (Right to Buy) 61.44 2020-02-25 4 A 0 22784 61.44 A 2027-02-24 Common Stock 22784.0 43105 D These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. /s/ Scott Lieberman, Attorney-in-fact 2020-02-27